Texas Judge Upholds FDA Authority in Eli Lilly Weight Loss Drug Shortage Dispute

In a recent legal development, a Texas federal judge upheld the U.S. Food and Drug Administration’s decision to remove Eli Lilly’s weight loss drug from the drug shortage list. The ruling effectively denies compounding pharmacies the ability to produce the medication. This decision confirms the FDA’s authority to regulate the availability of drugs based on current supply and demand conditions, reinforcing their ability to manage drug shortages in a dynamic healthcare market. For more details on the case, visit the official article on Law360.